New treatments for serpiginous choroiditis

Current Opinion in Ophthalmology

Volumn 14, Issue 3, 2003, Pages 128-131

  Akpek, Esen Karamursel ^a   Ilhan Sarac, Ozge ^a  

^a JOHNS HOPKINS UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALKYLATING AGENT; AZATHIOPRINE; CHLORAMBUCIL; CORTICOSTEROID; CYCLOPHOSPHAMIDE; CYCLOSPORIN; CYTARABINE; MYCOPHENOLIC ACID 2 MORPHOLINOETHYL ESTER; PREDNISOLONE; PREDNISONE; TACROLIMUS;

BONE MARROW SUPPRESSION; CHOROIDITIS; CLINICAL FEATURE; DISEASE COURSE; DRUG EFFICACY; DRUG TOLERABILITY; FLUORESCENCE ANGIOGRAPHY; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; LONG TERM CARE; PATHOGENESIS; PRIORITY JOURNAL; RECURRENT DISEASE; RELAPSE; REVIEW; SCAR FORMATION; SERPIGINOUS CHOROIDITIS; SIDE EFFECT; TREATMENT PLANNING; VISUAL ACUITY;

CHOROIDITIS; HUMANS;

EID: 0037678826     PISSN: 10408738     EISSN: None     Source Type: Journal    
DOI: 10.1097/00055735-200306000-00003     Document Type: Review

References (26)

1. Schatz H, Maumenee AE, Patz A: Geographic helicoid peripapillary choroidopathy. Trans Am Acad Ophthalmol Otolaryngol 1974, 78:P747-761.
2. Baarsma GS, Deutman AF: Serpiginous (geographic) choroiditis. Doc Ophthalmol 1976, 40:269-285.
3. Junius P: Seltene augenspiegelbilder zum klinischen phänomen der retinitis exsudativa coats und der retino-choroiditis "parapapillaris." Arch Augenheilkd 1932, 106:475-492.
4. Sorsby A: Choroidal angio-sclerosis with special reference to its hereditary character. Br J Ophthalmol 1939, 23:433-444.
5. Franceschetti A: A curious affection of the fundus oculi: helicoids peripapillar chorioretinal degeneration. Its relation to pigmentary paravenous chorioretinal degeneration. Doc Ophthalmol 1962, 16:81-110.
6. Laatikainen L, Erkkila H: Serpiginous choroiditis. Br J Ophthalmol 1974, 58:777-783.
7. Hamilton AM, Bird AC: Geographical choroidopathy. Br J Ophthalmol 1974, 58:784-797.
8. Jampol LM, Orth D, Daily MJ, et al.: Subretinal neovascularization with geographic (serpiginous) choroiditis. Am J Ophthalmol 1979, 88:683-689.
9. Weiss H, Annesley WH Jr, Shields JA, et al.: The clinical course of serpiginous choroidopathy. Am J Ophthalmol 1979, 87:133-142.
10. Akpek EK, Jabs DA, Tessler HH, et al.: Successful treatment of serpiginous choroiditis with alkylating agents. Ophthalmology 2002, 109:1506-1513. Immunosuppressive treatment with alkylating agents leads to long-term drug-free remission of serpiginous choroiditis.
11. Christmas NJ, Oh KT, Oh DM, et al.: Long-term follow-up of patients with serpiginous choroiditis. Retina 2002, 22:550-556. Although systemic corticosteroids are effective in halting the active choroiditis and shortening the duration of the inflammatory episode, they have no effects on prevention of recurrences. Immunosuppression appears to reduce the rate of recurrences.
12. Gass JDM: Stereoscopic Atlas of Macular Disease: Diagnosis and Treatment, edn 3. St. Louis: CV Mosby; 1987:136-144.
13. Wu JS, Lewis H, Fine SL, et al.: Clinicopathologic findings in a patient with serpiginous choroiditis and treated choroidal neovascularization. Retina 1989, 9:292-301.
14. Erkkila H, Laatikainen L, Jokinen E: Immunological studies on serpiginous choroiditis. Graefes Arch Clin Exp Ophthalmol 1982, 219:131-134.
15. Laatikainen L, Erkkila H: Subretinal and disc neovascularisation in serpiginous choroiditis. Br J Ophthalmol 1982, 66:326-331.
16. Laatikainen L, Erkkila H: A follow-up study on serpiginous choroiditis. Acta Ophthalmol (Copenh) 1981, 59:707-718.
17. Nussenblatt RB, Whitcup SM, Palestine AG: Uveitis: Fundamentals and Clinical Practice, edn 2. St. Louis: Mosby; 1996:368-370.
18. Hoyng C, Tilanus M, Deutman A: Atypical central lesions in serpiginous choroiditis treated with oral prednisone. Graefes Arch Clin Exp Ophthalmol 1998, 236:154-156.
19. Laatikainen L, Tarkkanen A: Failure of cyclosporin A in serpiginous choroiditis. J Ocul Ther Surg 1984, 3:280-283.
20. Secchi AG, Tognon MS, Maselli C: Cyclosporine A in the treatment of serpiginous choroiditis. Int Ophthalmol 1990, 14:395-399.
21. Araujo AA, Wells AP, Dick AD, et al.: Early treatment with cyclosporin in serpiginous choroidopathy maintains remission and good visual outcome. Br J Ophthalmol 2000, 84:979-982. Cyclosporin, as a monotherapy, is safe and effective to keep inflammation under control in patients with serpiginous choroiditis. Data on long-term remission are not adequate.
22. Hooper PL, Kaplan HJ: Triple agent immunosuppression in serpiginous choroiditis. Ophthalmology 1991, 98:944-951, discussion 951-952.
23. Munteanu G, Munteanu M, Zolog I: Serpiginous choroiditis-clinical study. Oftalmologia 2001, 52:72-80.
24. Vonmoos F, Messerli J, Moser HR, et al.: Immunosuppressive therapy in serpiginous choroiditis. Case report and brief review of the literature. Klin Monatsbl Augenheilkd 2001, 218:394-397.
25. Akpek EK, Baltatzis S, Yang J, et al.: Long-term immunosuppressive treatment of serpiginous choroiditis. Ocul Immunol Inflamm 2001, 9:153-167. Long-term immunosuppression with triple therapy appears to prolong remission and prevent vision loss in patients with serpiginous choroiditis.
26. Jabs DA, Rosenbaum JT, Foster CS, et al.: Guidelines for the use of immunosuppressive drugs in patients with ocular inflammatory disorders: recommendations of an expert panel. Am J Ophthalmol 2000, 130:492-513. Experts' recommendations regarding the use of various immunosuppressive agents used in the treatment of patients with inflammatory eye diseases have been reviewed in this article.